The Effect of Education on Drug Compliance and Quality of Life in Hepatitis B Patients

Istanbul University - Cerrahpasa (IUC)

Status: Unknown

Conditions: Hepatitis B, Chronic; Adherence, Medication; Quality of Life

Treatments: Behavioral: effectiveness of education

Study type: Interventional

Funder types: Other

Identifiers

NCT05286216

Sengul Korkmaz Binay Tez

Details and patient eligibility

About

The aim of this study is to determine the effect of the education given to patients with CHB who use oral antiviral drugs on oral antiviral drug use on drug compliance and quality of life.

Enrollment: 60 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Being diagnosed with CHB for at least 6 months,

  • To be over 18 years old,
  • Using oral antiviral treatment for at least three months,
  • To be a literate person,
  • No malignancy other than hepatocellular carcinoma,
  • Not having vision and hearing problems,
  • Not having cognitive or psychiatric problems,
  • Patients/patient relatives who can use smartphones (In order to invite the patients to the 3rd and 6th month controls and to inform and remind the experimental group about the training time, they / their relatives should have and can use a mobile phone)
  • Volunteer to participate in the study.

Exclusion criteria

• •Continuing to use alcohol after the first evaluation,

  • Not willing to participate in the study,
  • Patients with a psychiatric diagnosis,
  • Patients who do not meet the sample inclusion criteria.

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

60 participants in 2 patient groups

Experimental group

Experimental group

Description:

Patient diagnosis form with CHB and related scales (Patient Diagnosis Form with Chronic Hepatitis B, Medication Adherence Report Scale-5), Medication Adherence Report Scale (MedTake Test), Chronic Liver Disease Quality of Life Scale 2.0" (Liver Disease Symptom Index 2.0 (LDSI 2.0), Health-Related Quality of Life Scale SF-12" (12 Item Short Form Health Survey) (Short Form 12 - SF 12), Patient Learning Needs Scale will be applied before the intervention. The training will be in two modules and two different sessions. The effectiveness of the training will be evaluated by re-applying the scales 12 weeks and 24 weeks after the training.

Treatment:

Behavioral: effectiveness of education

Control group

No Intervention group

Description:

Patient diagnosis form with CHB and related scales (Patient Diagnosis Form with Chronic Hepatitis B, Medication Adherence Report Scale-5), Medication Adherence Report Scale (MedTake Test), Chronic Liver Disease Quality of Life Scale 2.0" (Liver Disease Symptom Index 2.0 (LDSI 2.0), Health-Related Quality of Life Scale SF-12" (12 Item Short Form Health Survey) (Short Form 12 - SF 12), Patient Learning Needs Scale in the first evaluation, 12 weeks and 24 weeks later, the scales were re-applied and the education was improved. effectiveness will be evaluated.